Literature DB >> 26661202

Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Matteo Tonietto1, Gaia Rizzo1, Mattia Veronese2, Masahiro Fujita3, Sami S Zoghbi3, Paolo Zanotti-Fregonara4, Alessandra Bertoldo5.   

Abstract

Full kinetic modeling of dynamic PET images requires the measurement of radioligand concentrations in the arterial plasma. The unchanged parent radioligand must, however, be separated from its radiometabolites by chromatographic methods. Thus, only few samples can usually be analyzed and the resulting measurements are often noisy. Therefore, the measurements must be fitted with a mathematical model. This work presents a comprehensive analysis of the different models proposed in the literature to describe the plasma parent fraction (PPf) and of the alternative approaches for radiometabolite correction. Finally, we used a dataset of [(11)C]PBR28 brain PET data as a case study to guide the reader through the PPf model selection process.
© The Author(s) 2015.

Entities:  

Keywords:  PET; PPf modeling; plasma parent fraction; radiometabolite correction

Mesh:

Substances:

Year:  2015        PMID: 26661202      PMCID: PMC4759680          DOI: 10.1177/0271678X15610585

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  68 in total

1.  Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.

Authors:  Sascha Mitkovski; Victor L Villemagne; Kathy E Novakovic; Graeme O'Keefe; Henri Tochon-Danguy; Rachel S Mulligan; Kerryn L Dickinson; Tim Saunder; Marie-Claude Gregoire; Michel Bottlaender; Frederic Dolle; Christopher C Rowe
Journal:  Nucl Med Biol       Date:  2005-08       Impact factor: 2.408

Review 2.  Image-derived input function for brain PET studies: many challenges and few opportunities.

Authors:  Paolo Zanotti-Fregonara; Kewei Chen; Jeih-San Liow; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-03       Impact factor: 6.200

3.  Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106.

Authors:  Yoko Ikoma; Fumihiko Yasuno; Hiroshi Ito; Tetsuya Suhara; Miho Ota; Hinako Toyama; Yota Fujimura; Akihiro Takano; Jun Maeda; Ming-Rong Zhang; Ryuji Nakao; Kazutoshi Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-10       Impact factor: 6.200

4.  Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.

Authors:  Miikka Tarkia; Antti Saraste; Tiina Saanijoki; Vesa Oikonen; Tommi Vähäsilta; Marjatta Strandberg; Christoffer Stark; Tuula Tolvanen; Mika Teräs; Timo Savunen; Mark A Green; Juhani Knuuti; Anne Roivainen
Journal:  Nucl Med Biol       Date:  2012-01-20       Impact factor: 2.408

5.  Imaging of monoamine oxidase-A in the human brain with [11C]befloxatone: quantification strategies and correlation with mRNA transcription maps.

Authors:  Paolo Zanotti-Fregonara; Claire Leroy; Gaia Rizzo; Dimitri Roumenov; Christian Trichard; Jean-Luc Martinot; Michel Bottlaender
Journal:  Nucl Med Commun       Date:  2014-12       Impact factor: 1.690

6.  Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.

Authors:  Takeshi Sasaki; Hiroshi Ito; Yasuyuki Kimura; Ryosuke Arakawa; Harumasa Takano; Chie Seki; Fumitoshi Kodaka; Saori Fujie; Keisuke Takahata; Tsuyoshi Nogami; Masayuki Suzuki; Hironobu Fujiwara; Hidehiko Takahashi; Ryuji Nakao; Toshimitsu Fukumura; Andrea Varrone; Christer Halldin; Toru Nishikawa; Tetsuya Suhara
Journal:  J Nucl Med       Date:  2012-06-11       Impact factor: 10.057

7.  Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.

Authors:  Marie-Anne Peyronneau; Wadad Saba; Sébastien Goutal; Annelaure Damont; Frédéric Dollé; Michael Kassiou; Michel Bottlaender; Héric Valette
Journal:  Drug Metab Dispos       Date:  2012-10-12       Impact factor: 3.922

8.  Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

Authors:  H Kuwabara; P Cumming; J Reith; G Léger; M Diksic; A C Evans; A Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  1993-01       Impact factor: 6.200

Review 9.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

10.  Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.

Authors:  Alexander Hammers; Marie-Claude Asselin; Federico E Turkheimer; Rainer Hinz; Safiye Osman; Gary Hotton; David J Brooks; John S Duncan; Matthias J Koepp
Journal:  Neuroimage       Date:  2007-07-24       Impact factor: 6.556

View more
  10 in total

1.  The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions.

Authors:  Annette Johansen; Hanne D Hansen; Claus Svarer; Szabolcs Lehel; Sebastian Leth-Petersen; Jesper L Kristensen; Nic Gillings; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

2.  Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11C-PBR28.

Authors:  Paolo Zanotti-Fregonara; William C Kreisl; Robert B Innis; Chul Hyoung Lyoo
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

3.  Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.

Authors:  Sylvain Auvity; Matteo Tonietto; Fabien Caillé; Benedetta Bodini; Michel Bottlaender; Nicolas Tournier; Bertrand Kuhnast; Bruno Stankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-04       Impact factor: 9.236

Review 4.  Positron emission tomography in multiple sclerosis - straight to the target.

Authors:  Benedetta Bodini; Matteo Tonietto; Laura Airas; Bruno Stankoff
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

5.  Non-invasive kinetic modelling of PET tracers with radiometabolites using a constrained simultaneous estimation method: evaluation with 11C-SB201745.

Authors:  Hasan Sari; Kjell Erlandsson; Lisbeth Marner; Ian Law; Henrik B W Larsson; Kris Thielemans; Sébastien Ourselin; Simon Arridge; David Atkinson; Brian F Hutton
Journal:  EJNMMI Res       Date:  2018-07-03       Impact factor: 3.138

Review 6.  Supervised clustering for TSPO PET imaging.

Authors:  Julia Schubert; Matteo Tonietto; Federico Turkheimer; Paolo Zanotti-Fregonara; Mattia Veronese
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-29       Impact factor: 9.236

7.  Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.

Authors:  Sudhakar Selvaraj; Peter S Bloomfield; Bo Cao; Mattia Veronese; Federico Turkheimer; Oliver D Howes
Journal:  Schizophr Res       Date:  2017-10-12       Impact factor: 4.939

8.  Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.

Authors:  Gitte M Knudsen; Melanie Ganz; Stefan Appelhoff; Ronald Boellaard; Guy Bormans; Richard E Carson; Ciprian Catana; Doris Doudet; Antony D Gee; Douglas N Greve; Roger N Gunn; Christer Halldin; Peter Herscovitch; Henry Huang; Sune H Keller; Adriaan A Lammertsma; Rupert Lanzenberger; Jeih-San Liow; Talakad G Lohith; Mark Lubberink; Chul H Lyoo; J John Mann; Granville J Matheson; Thomas E Nichols; Martin Nørgaard; Todd Ogden; Ramin Parsey; Victor W Pike; Julie Price; Gaia Rizzo; Pedro Rosa-Neto; Martin Schain; Peter Jh Scott; Graham Searle; Mark Slifstein; Tetsuya Suhara; Peter S Talbot; Adam Thomas; Mattia Veronese; Dean F Wong; Maqsood Yaqub; Francesca Zanderigo; Sami Zoghbi; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

9.  [18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.

Authors:  Rohini Sharma; Pablo Oriol Valls; Marianna Inglese; Suraiya Dubash; Michelle Chen; Hani Gabra; Ana Montes; Amarnath Challapalli; Mubarik Arshad; George Tharakan; Ed Chambers; Tom Cole; Jingky P Lozano-Kuehne; Tara D Barwick; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-21       Impact factor: 9.236

10.  Development of a non-radiometric method for measuring the arterial input function of a 11C-labeled PET radiotracer.

Authors:  H Umesha Shetty; Sami S Zoghbi; Cheryl L Morse; Aneta Kowalski; Jussi Hirvonen; Robert B Innis; Victor W Pike
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.